-
Symbol
-
CASI on Nasdaq
-
Investment type
-
Equity / Ordinary Share
-
Latest Disclosed Ownership
-
980K shares
-
Security Ownership
-
6.3%
Foresite Capital Fund VI LP ownership in CASI Pharmaceuticals, Inc. Ordinary Share (CASI)
2025-11-14 - Foresite Capital Fund VI LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 980K shares of CASI Pharmaceuticals, Inc. Ordinary Share (CASI).
This represents 6.3% percent ownership of the company.
In their previous filing dated 2025-08-12, Foresite Capital Fund VI LP had reported owning 787K shares, indicating an increase of 24.5% percent.